• Je něco špatně v tomto záznamu ?

Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses

J. Hrdý, J. Alard, A. Couturier-Maillard, O. Boulard, D. Boutillier, M. Delacre, C. Lapadatescu, A. Cesaro, P. Blanc, B. Pot, B. Ryffel, M. Chamaillard, C. Grangette,

. 2020 ; 10 (1) : 5345. [pub] 20200324

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028363

Crohn's disease is linked to a decreased diversity in gut microbiota composition as a potential consequence of an impaired anti-microbial response and an altered polarization of T helper cells. Here, we evaluated the immunomodulatory properties of two potential probiotic strains, namely a Bifidobacterium animalis spp. lactis Bl 5764 and a Lactobacillus reuteri Lr 5454 strains. Both strains improved colitis triggered by either 2,4,6-trinitrobenzenesulfonic acid (TNBS) or Citrobacter rodentium infection in mice. Training of dendritic cells (DC) with Lr 5454 efficiently triggered IL-22 secretion and regulatory T cells induction in vitro, while IL-17A production by CD4+ T lymphocytes was stronger when cultured with DCs that were primed with Bl 5764. This strain was sufficient for significantly inducing expression of antimicrobial peptides in vivo through the Crohn's disease predisposing gene encoding for the nucleotide-binding oligomerization domain, containing protein 2 (NOD2). In contrast, NOD2 was dispensable for the impact on antimicrobial peptide expression in mice that were monocolonized with Lr 5454. In conclusion, our work highlights a differential mode of action of two potential probiotic strains that protect mice against colitis, providing the rational for a personalized supportive preventive therapy by probiotics for individuals that are genetically predisposed to Crohn's disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028363
003      
CZ-PrNML
005      
20210114153632.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-020-62161-1 $2 doi
035    __
$a (PubMed)32210304
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Hrdý, Jiří $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses / $c J. Hrdý, J. Alard, A. Couturier-Maillard, O. Boulard, D. Boutillier, M. Delacre, C. Lapadatescu, A. Cesaro, P. Blanc, B. Pot, B. Ryffel, M. Chamaillard, C. Grangette,
520    9_
$a Crohn's disease is linked to a decreased diversity in gut microbiota composition as a potential consequence of an impaired anti-microbial response and an altered polarization of T helper cells. Here, we evaluated the immunomodulatory properties of two potential probiotic strains, namely a Bifidobacterium animalis spp. lactis Bl 5764 and a Lactobacillus reuteri Lr 5454 strains. Both strains improved colitis triggered by either 2,4,6-trinitrobenzenesulfonic acid (TNBS) or Citrobacter rodentium infection in mice. Training of dendritic cells (DC) with Lr 5454 efficiently triggered IL-22 secretion and regulatory T cells induction in vitro, while IL-17A production by CD4+ T lymphocytes was stronger when cultured with DCs that were primed with Bl 5764. This strain was sufficient for significantly inducing expression of antimicrobial peptides in vivo through the Crohn's disease predisposing gene encoding for the nucleotide-binding oligomerization domain, containing protein 2 (NOD2). In contrast, NOD2 was dispensable for the impact on antimicrobial peptide expression in mice that were monocolonized with Lr 5454. In conclusion, our work highlights a differential mode of action of two potential probiotic strains that protect mice against colitis, providing the rational for a personalized supportive preventive therapy by probiotics for individuals that are genetically predisposed to Crohn's disease.
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika nesteroidní $x farmakologie $7 D000894
650    12
$a Bifidobacterium animalis $7 D000069982
650    _2
$a Citrobacter rodentium $x patogenita $7 D044082
650    _2
$a kolitida $x chemicky indukované $x mikrobiologie $x patologie $x terapie $7 D003092
650    _2
$a dendritické buňky $x fyziologie $7 D003713
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a enterobakteriální infekce $x mikrobiologie $7 D004756
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a střevní mikroflóra $7 D000069196
650    _2
$a gnotobiologické modely $7 D005856
650    12
$a Limosilactobacillus reuteri $7 D052200
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a proteiny asociované s pankreatitidou $x genetika $7 D000073718
650    _2
$a probiotika $x farmakologie $7 D019936
650    _2
$a T-lymfocyty pomocné-indukující $x fyziologie $7 D006377
650    _2
$a regulační T-lymfocyty $x fyziologie $7 D050378
650    _2
$a kyselina trinitrobenzensulfonová $x toxicita $7 D014302
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Alard, Jeanne $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France.
700    1_
$a Couturier-Maillard, Aurelie $u INEM - UMR7355, Molecular Immunology, CNRS, University of Orleans, Orleans, France. Institute of Infectious Diseases and Molecular Medicine (IDM), and Infectious Diseases, Division of Immunology and South African Medical Research Council (SAMRC) Immunology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, RSA.
700    1_
$a Boulard, Olivier $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France.
700    1_
$a Boutillier, Denise $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France.
700    1_
$a Delacre, Myriam $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France.
700    1_
$a Lapadatescu, Carmen $u Department of Clinical Immunology, BioProx, Paris, France.
700    1_
$a Cesaro, Annabelle $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France.
700    1_
$a Blanc, Philippe $u Department of Clinical Immunology, BioProx, Paris, France.
700    1_
$a Pot, Bruno $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. Research Group of Industrial Microbiology and Food Biotechnology, Faculty of Sciences and Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
700    1_
$a Ryffel, Bernhard $u INEM - UMR7355, Molecular Immunology, CNRS, University of Orleans, Orleans, France. Institute of Infectious Diseases and Molecular Medicine (IDM), and Infectious Diseases, Division of Immunology and South African Medical Research Council (SAMRC) Immunology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, RSA.
700    1_
$a Chamaillard, Mathias $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. mathias.chamaillard@inserm.fr. Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France. mathias.chamaillard@inserm.fr.
700    1_
$a Grangette, Corinne $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. corinne.grangette@pasteur-lille.fr.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 10, č. 1 (2020), s. 5345
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32210304 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153629 $b ABA008
999    __
$a ok $b bmc $g 1608698 $s 1119543
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 1 $d 5345 $e 20200324 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace